Peptides craze meets caution: unregulated injections spark safety and regulatory questions
TL;DR
A wellness-driven surge in peptide injections touted for healing, recovery, and muscle-building rests on limited clinical evidence and carries safety risks. In 2023 the FDA banned production of several peptides by compounding pharmacies due to safety concerns and impurities, and the agency does not approve such compounds. US policy discussions about legalizing broader compounding could boost access but also risk, as product quality and dosing vary and most data come from animal studies. Experts urge caution and emphasize that rigorous human trials are still needed to establish true benefits and safety.
- The US is hooked on unregulated peptides. But are they effective, or even safe? Live Science
- Peptides are everywhere in health and beauty, but does the science actually back up the claims? Scripps News
- Peptide hype is at an all-time high – I found out the truth The Independent
- The hidden risks of grey-market peptides – why women face greater danger The Conversation
- Peptides 101: Why gay men are turning to black-market injectables to build muscle out.com
Want the full story? Read the original reporting
Read on Live Science